Home » Pharma News » Cipla divests 16.7 per cent stake in Chase Pharma to Allergan

Cipla divests 16.7 per cent stake in Chase Pharma to Allergan

Cipla divests 16.7 per cent stake in Chase Pharma to Allergan

Drug major CiplaBSE 0.45 % today said Chase Pharmaceuticals Corporation, in which it has 16.7 per cent stake has been acquired by Ireland-headquartered Allergan plc.

Delaware-based Chase Pharmaceuticals Corporation, in which the company’s UK arm Cipla (EU) Ltd has 16.7 per cent stake, has been acquired by a subsidiary of Allergan plc, Cipla said in a statement.

“Allergan has agreed to pay $125 million upfront plus potential regulatory and commercial milestones of up to  ..

Thanks for the comment

BIGTheme.net • Free Website Templates - Downlaod Full Themes